HRTX (Heron Therapeutics) OCF Margin %: -4.44% (As of Mar. 2026)


HRTX Heron Therapeutics Inc HRTX
49 GF Score
Price $0.43
GF Value $1.53
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Heron Therapeutics OCF Margin %?

Heron Therapeutics HRTX +4.04% 49 OCF Margin % is -4.44% as of Mar. 2026. GuruFocus rates HRTX with a GF Score™ of 49/100 and a GF Value™ of $1.53 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 959 Biotechnology companies, Heron Therapeutics ranks better than 60.79% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Heron Therapeutics's Cash Flow from Operations for the three months ended in Mar. 2026 was $-1.5 Mil. Heron Therapeutics's Revenue for the three months ended in Mar. 2026 was $34.7 Mil. Therefore, Heron Therapeutics's OCF Margin % for the quarter that ended in Mar. 2026 was -4.44%.

As of today, Heron Therapeutics's current OCF Yield % is -24.70%.

The historical rank and industry rank for Heron Therapeutics's OCF Margin % or its related term are showing as below:

HRTX' s OCF Margin % Range Over the Past 10 Years
Min: -10484.52   Med: -172.48   Max: -15.61
Current: -13.44

During the past 13 years, the highest OCF Margin % of Heron Therapeutics was -15.61%. The lowest was -10484.52%. And the median was -172.48%.

HRTX's OCF Margin % is ranked better than
60.79% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs HRTX: -13.44

Heron Therapeutics OCF Margin % Related Terms

Heron Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Heron Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Heron Therapeutics OCF Margin % Chart

Heron Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -235.51 -136.44 -46.27 -15.61 -17.81

Heron Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.80 -29.22 3.48 -22.63 -4.44

HRTX vs PLYX, ORMP, SPRO: OCF Margin % Comparison

For the Biotechnology subindustry, Heron Therapeutics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Heron Therapeutics OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Heron Therapeutics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Heron Therapeutics's OCF Margin % falls into.


HRTX
49GF Score
Heron Therapeutics Inc HRTX
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Heron Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Heron Therapeutics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-27.591/154.904
=-17.81 %

Heron Therapeutics's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-1.54/34.711
=-4.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -4.44% mean?
Heron Therapeutics (HRTX) has a OCF Margin % of -4.44% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Heron Therapeutics and its competitors. According to the industry distribution chart, Heron Therapeutics ranks #376 out of 959 companies in the Biotechnology industry, placing it in the top 39.2%.
Is Heron Therapeutics' OCF Margin % too high?
Heron Therapeutics' current OCF Margin % is -4.44%. Based on the distribution chart, Heron Therapeutics ranks #376 out of 959 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Heron Therapeutics has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Heron Therapeutics' OCF Margin % compare to PLYX and ORMP?
According to the Biotechnology industry distribution chart, Heron Therapeutics ranks #376 out of 959 companies for OCF Margin %. This puts Heron Therapeutics in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Heron Therapeutics and its competitors. Heron Therapeutics's current OCF Margin % is -4.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Heron Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Heron Therapeutics (HRTX) is currently considered Possible Value Trap. The stock's GF Value™ is $1.53, compared to a current price of $0.43 — trading 71.7% below its estimated fair value. The current OCF Margin % is -4.44%. Heron Therapeutics' overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Heron Therapeutics (HRTX), the current OCF Margin % is -4.44% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Heron Therapeutics (HRTX) Overvalued in 2026?

Based on GuruFocus' analysis, Heron Therapeutics stock appears to be undervalued. The current stock price of $0.43 is trading 71.7% below its estimated GF Value™ of $1.53. GuruFocus considers Heron Therapeutics to be Possible Value Trap.

Key valuation signals for HRTX:

  • OCF Margin %: -4.44%
  • GF Value™: $1.53 vs. price of $0.43 (71.7% below fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the HRTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Heron Therapeutics Business Description

Other Exchanges 0J4V:UKAXD2:Germany
Address 100 Regency Forect Drive, Suite 300, Cary, NC, USA, 27518
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
49GF Score

Get the complete analysis for HRTX

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.43
Price
$1.53
GF Value